EGFR Mutation Subtype and Risk of Brain Metastases From Non-Small Cell Lung Cancer in the Osimertinib Era: EGFR Subtype and Brain Metastases in NSCLC.

Tagrisso (osimertinib) - AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42742045

Ameya Patel; Amin H Nassar; Henry S Park; So Yeon Kim; Victor Lee

Sep 16, 2026